TORVANTA
Other · S&P 500 · data as of 2026-10-05

XNCR stock analysis: XNCR

XNCR (XNCR) is an S&P 500 company in Other. It grades strongest on momentum and weakest on profitability.

The model's view of XNCR · subscribers

Where XNCR ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with XNCR · updated 2026-10-05 · from prices and SEC filings

XNCR price performance

XNCR against the S&P 500, one year
+0%+50%+100%+150%XNCR +122%S&P 500 +18%2025-09-292026-10-05
Year to date+67.4%S&P 500 +14.5% · ahead by 52.9 pts
1 year+117.8%S&P 500 +17.0% · ahead by 100.7 pts
3 years+30.3%S&P 500 +89.3% · behind by 59.0 pts
5 years-28.4%S&P 500 +91.3% · behind by 119.7 pts

Total returns with dividends reinvested.

XNCR factor grades

Each grade compares XNCR with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

–ValueFCF yield -10.9% (industry 6.0%)
–GrowthRevenue growth -33% (industry +8%)
FProfitabilityOperating margin -205.8% (industry 9.6%)ROIC -30.3% (industry 10.1%)
A-Momentum12-month change +118%From 52-wk high -13%

XNCR in plain numbers

XNCR key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$1.9B
Revenue growth (y/y)-33%
Free-cash-flow yield-10.9%
Dividend yieldn/a
Next earnings (expected)2026-11-04
Valuation measures
Market value$1.9B
Enterprise value$2.0B
Price / sales18.2x
Price / book3.8x
EV / revenue18.7x
Financial highlights
Revenue, last 12 months$105.0M
Net income, last 12 months-$163.3M
EPS, last 12 months (GAAP)$-2.17
Operating margin-205.8%
Net margin-155.6%
Return on equity-29.1%
Return on invested capital-30.3%
Cash$44.7M
Total debt$104.9M
Debt / equity0.21x
Free cash flow, last 12 months-$208.3M
Current ratio6.39x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

XNCR earnings trends

Revenue vs earnings
-$128.9M-$79.2M-$29.4M$20.3M$70.0MSep 2024 Revenue: $10.7MDec 2024 Revenue: $70.0MMar 2025 Revenue: $32.7MJun 2025 Revenue: $43.6MSep 2025 Revenue: $21.0MDec 2025 Revenue: $28.2MMar 2026 Revenue: $4.5MJun 2026 Revenue: $51.2MSep 2024 Net income: -$45.1MDec 2024 Net income: -$53.5MMar 2025 Net income: -$48.4MJun 2025 Net income: -$30.8MSep 2025 Net income: -$6.0MDec 2025 Net income: -$6.7MMar 2026 Net income: -$128.9MJun 2026 Net income: -$21.7MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: -421.5%Net margin: -76.4%Net margin: -147.9%Net margin: -70.7%Net margin: -28.7%Net margin: -23.6%Net margin: -2854.7%Net margin: -42.4%-2855%-1439%-24%■ Revenue ■ Net income ━ Net margin
Earnings per share$-1.7$-1.3$-0.9$-0.4$0.0Sep 2024 EPS (GAAP, diluted): $-0.7Dec 2024 EPS (GAAP, diluted): $-0.7Mar 2025 EPS (GAAP, diluted): $-0.7Jun 2025 EPS (GAAP, diluted): $-0.4Sep 2025 EPS (GAAP, diluted): $-0.1Dec 2025 EPS (GAAP, diluted): $-0.1Mar 2026 EPS (GAAP, diluted): $-1.7Jun 2026 EPS (GAAP, diluted): $-0.3Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted)

From the company's 10-Q and 10-K filings with the SEC.

XNCR financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$275.1M$164.6M$168.3M$110.5M$125.6M
Net income$82.6M-$55.2M-$126.1M-$232.6M-$91.9M
EPS (GAAP)$1.35$-0.94$-2.10$-3.60$-1.24
Free cash flow-$30.2M-$14.0M$66.7M-$208.3M-$138.3M

XNCR earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-05$-0.29n/a+17%+0.8%
2026-07-29$-0.29n/a+17%+7.5%
2026-05-06$-1.71n/a-86%-5.3%
2026-02-25$-0.09n/a-60%+14.4%
2026-01-08$-0.09n/a-60%-7.7%
2025-11-05$-0.08n/a+96%+2.9%

About XNCR

HeadquartersPasadena, CA
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq

From the company's SEC registration record.

Companies similar to XNCR

CompanyMarket valueP/ERevenue growthOperating margin12-month change
XNCR XNCR$1.9Bn/a-33%-205.8%+118%
WU WU$1.9B5.0x-2%15.9%-14%compare
ZD ZD$1.9B3.2x-8%5.5%+43%compare
BLFS BLFS$1.9B33.0x+34%2.9%+45%compare
UNIT UNIT$1.9B5.1x+200%3.2%+36%
AZTA AZTA$1.9Bn/a+5%-28.6%+32%
WKC WKC$1.9Bn/a+8%-0.1%+44%

All Other stock ratings

Frequently asked questions

Is XNCR stock a buy?

Torvanta does not tell individuals what to buy. Its grades for XNCR are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does XNCR report earnings next?

Based on its filing history, Torvanta expects XNCR to report around 2026-11-04.

How has XNCR performed against the S&P 500?

Over the past year XNCR returned +117.8%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer